3x Clinical partnership growth

Marketing for Genomics & Precision Medicine Startups

Genomic sequencing, genetic testing, precision oncology, and personalized medicine platforms. Cactus Marketing specializes in marketing for Genomics companies — we understand the unique growth challenges you face and have proven playbooks to turn them into competitive advantages.

Genomics companies face challenges that generic marketing agencies simply don't understand: Consumer genetic privacy concerns, Physician and researcher dual buyer, Insurance coverage and reimbursement messaging, Long regulatory pathways. We've spent years developing frameworks specifically for Genomics & Precision Medicine Startups — so you get a partner who already knows your buyer, your sales cycle, and what moves the needle.

Marketing Challenges We Solve for Genomics Companies

  • Consumer genetic privacy concerns
  • Physician and researcher dual buyer
  • Insurance coverage and reimbursement messaging
  • Long regulatory pathways

How We Help Genomics & Precision Medicine Startups

Fractional CMO

Senior marketing leadership embedded in your startup — strategy, execution, and team-building at a fraction of a full-time CMO cost.

Learn more →

Go-to-Market Strategy

End-to-end GTM planning covering ICP definition, channel selection, messaging, launch sequencing, and revenue milestones.

Learn more →

Demand Generation

Full-funnel demand generation that fills your pipeline with qualified leads — outbound, inbound, email automation, CRM, and conversion optimization.

Learn more →

We've worked with over 3x Clinical partnership growth at every stage — from pre-revenue through post-IPO. Our engagements are hands-on: we embed with your team, own the marketing function, and measure success in pipeline and revenue — not vanity metrics.

Ready to accelerate your Genomics marketing?

Book a free 30-minute strategy call. We'll review your current marketing, identify the biggest opportunities, and share a specific growth plan for your company.

Book a free strategy call →